A. Hamoud

Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?

R. Mccullumsmith, S. O’Donovan, Nicholas D. Henkel, 2022, International journal of molecular sciences.

Biliverdin reductase and bilirubin in hepatic disease.

T. Hinds, D. Stec, Abdul-Rizaq Hamoud, 2018, American journal of physiology. Gastrointestinal and liver physiology.

Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator–activated receptor α

T. Hinds, R. Mccullumsmith, D. Stec, 2020, The Journal of Biological Chemistry.

Bilirubin in the Liver–Gut Signaling Axis

T. Hinds, D. Stec, Abdul-Rizaq Hamoud, 2018, Trends in Endocrinology & Metabolism.

Piplartine attenuates aminoglycoside-induced TRPV1 activity and protects from hearing loss in mice

Katyarina E. Brunette, Huizhan Liu, Martin Conda-Sheridan, 2024, Science Translational Medicine.

In silico transcriptome screens identify epidermal growth factor receptor inhibitors as therapeutics for noise-induced hearing loss

S. Lovas, Sarath Vijayakumar, P. Dabestani, 2024, Science advances.

The active kinome: The modern view of how active protein kinase networks fit in biological research.

J. Meller, R. Mccullumsmith, Ali S. Imami, 2021, Current opinion in pharmacology.

Gene Enrichment Analysis of Astrocyte Subtypes in Psychiatric Disorders and Psychotropic Medication Datasets

V. Parpura, R. Mccullumsmith, Ali S. Imami, 2022, Cells.

Alterations in protein kinase networks in astrocytes and neurons derived from patients with familial Alzheimer’s Disease

T. Ma, R. Mccullumsmith, Ali S. Imami, 2022, bioRxiv.